Reviews/Sleep and Metabolic Health/Circadian misalignment and glucose
Circ · SMH-CIRC-02 · v2
Borderline: within 4 points of the Established/Likely boundary, so a re-grade could land either side.
Several carefully controlled human experiments deliberately flipped people's day-night schedules in a laboratory while holding meals and activity constant, so that only the clock mismatch differed. In each, the body handled sugar less well under the mismatched schedule than under the aligned one, and the mechanism pointed to the body's cells becoming less responsive to insulin [16]. Animal studies that scrambled day-night cycles showed the same direction of harm [22], [24]. Some of the supporting human work also cut sleep short, so part of the signal cannot be cleanly separated from sleep loss [6], [7]. The panel treated the evidence as directly on point and consistent in direction, while noting the studies were small and that the two strongest came from one research group.
Three human randomized crossover experiments isolated circadian misalignment from behaviour and each showed reduced glucose tolerance: [4] found postprandial glucose 5.6% higher under misalignment independent of behavioural and circadian effects, [16] found misalignment reduced glucose tolerance mainly by lowering insulin sensitivity, and [23] found glucose and insulin area under the curve increased during misalignment. Two animal desynchronization models reproduced the effect: a diurnal rodent under chronic night shift showed impaired glucose tolerance [22] and a gestational hamster under reversed light-dark cycle showed impaired glucose clearance and hyperglycaemia [24]. Supporting human studies add a same-direction signal but under sleep loss, with insulin sensitivity decreased about 13% [6] and postprandial glucose elevated after total sleep deprivation [7]. The outcomes are physiological measures of glucose handling that match the wording of the claim. The contested point: The corpus does not divide on the direction of the effect; every on-claim study points the same way. The live questions are how independent and how precise the human evidence is, given that the two strongest isolating studies [4] and [16] come from the same group and the isolating studies are small (N=14 in [16] and [23]).
All 24 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Sleep and Metabolic Health, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The two strongest human studies [4] and [16] originate from the same Brigham (Morris/Scheer) research group and share methodology, so they are not fully independent replications of the misalignment effect.
The isolating human experiments are small (N=14 in [16] and [23]) and effect sizes modest ([4]: +5.6% postprandial glucose), limiting precision despite statistical significance.
Where it remains uncertain. The isolating human studies are small (N=14 in [16] and [23]) and two of the strongest [4], [16] share a research group, while the supporting studies [6], [7] confound misalignment with sleep loss.
Aleatory
The isolating human studies enrol 14 adults ([16], [23]), so individual variation leaves the effect estimates imprecise even where statistically significant.
Epistemic
[4] and [16] originate from the same research group and share methodology, so convergence partly reflects one lineage rather than fully independent confirmation.
Inferential
[22] (diurnal rodent) and [24] (gestational hamster) support the claim only by inference to humans, and [24]'s pregnancy physiology narrows generalisability.
The load-bearing papers from a corpus of 24, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Primary human crossover evidence that misalignment per se raises postprandial glucose, isolated from behaviour and circadian phase.
“Circadian misalignment increased postprandial glucose by 5.6%, independent of behavioral and circadian effects (P = .0042).”
Panel auditInternal validity: high · scope of inference: Healthy chronic shift workers under a 12-hour inverted behavioral/environmental cycle.Key limitations: sample size not stated in abstract · simulated rather than field shift work
Supporting evidence linking circadian phase delay to reduced insulin sensitivity, confounded with sleep restriction.
“in WR, whole-body, hepatic, and muscle insulin sensitivity decreased ∼9%-27% during recurrent insufficient sleep versus baseline.”
Panel auditInternal validity: medium · scope of inference: Healthy young adults under sleep restriction with and without weekend recovery.Key limitations: sleep loss confounded with circadian delay · small groups · insulin sensitivity not glucose tolerance test
Supporting human evidence that shift-work-like circadian disruption raises postprandial glucose, though confounded with sleep loss.
“whereas postprandial plasma glucose concentrations were elevated after TSD (7.77 ± 1.63 vs 6.59 ± 1.32 mmol/L; P = .011).”
Panel auditInternal validity: medium · scope of inference: Healthy men after one night of total sleep deprivation.Key limitations: sleep deprivation not a misalignment paradigm · men only · single-night exposure
3 of 24 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
Multiple design-isolated human crossover studies plus animal convergence directly carry the claim, held just below Established by small samples and partial research-group overlap.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Independent, adequately powered human replication. The two strongest isolating studies [4] and [16] share a group and enrol 14 subjects [16], leaving independence and precision unresolved. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A larger forced-desynchrony or simulated-shift crossover run by an unrelated centre, pre-registered, with glucose tolerance as primary outcome.
Open question: Does circadian misalignment reduce glucose tolerance to the same degree outside the Brigham group's protocols and in larger samples? Why it is still open: The isolating human evidence [4], [16], [23] is small and partly single-lineage.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 23 Oct 2026 · protocol v0.19